We're short Aterian $ATER, formerly known as Mohawk Group Holdings $MWK. Our full report is now available culperresearch.com
2) Aterian $ATER has ties to convicted criminals and is promoting what we believe is an overhyped "AI" narrative and a string of garbage acquisitions. ATER shares are up ~300% as investors salivate over the Company's recent M&A, yet we find the deals to be utter garbage.
3) In Feb 2021, $ATER acquired "Healing Solutions" ("HS") from Jason Hope, who ran alleged text messaging scam JAWA, which was sued by the Texas AG. $ATER calls HS a "recurring revenue" business, yet our analysis of import records suggests 62% of the business is hand sanitizers.
4) HS's final shipment of sanitizers was received August 2020: we think this business is never coming back. Hope himself stated "the terms we got from $ATER were far superior to other offers" suggesting even he knows he took $ATER for a ride. Hope's lock-up expires on August 2.
5) In Dec 2020, $ATER purchased "the Smash Assets" from felon Mikial Nijjar. 5 months later, $ATER is still unable to provide audited financials for the acquisition, leaving its S-3 shelf ineligible. Nijjar's lock-up expires in June.
6) In Aug 2020, $ATER acquired Truweo from Muhammad Sikandar, "7 Figure Kindle Tycoon". Truweo sells a $19.99 back brace whose Amazon rankings have fallen off a cliff since being acquired. $ATER calls these acquisitions "historical opportunities". We think they're garbage.
7) We think $ATER's "AIMEE" is more a stock promotion tool than a real AI player. Customers have been in pilot programs since 2018, yet revenues remain miniscule and decreased in 2020. One former customer estimated $ATER only had one-third of the capabilities it claimed.
8) 5 additional $ATER employees cast doubt on AIMEE, calling it "very simple" and asking "how much of this is AI…" We think $ATER product launches are aided instead by hidden Facebook groups and massive rebate programs, "gray area" tactics which can get sellers booted from AMZN.
9) We think $ATER's core business is nosediving. For ex. in $ATER's largest category, its hOmeLabs dehumidifiers went from a #41 ranking a year ago to #830 today. The Company's 2021 guidance doesn't even meet the estimated EBITDA from acquired businesses.
10/10) Over 25% of $ATER shares are now owned by 2 felons & 2 alleged fraudsters. We think they now face a prisoner's dilemma as lock-ups expire. Past the AI and flywheel fairytales, we see a reseller of cheap Chinese goods whose business is imploding. We're short.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
1) We are short The Bancorp, Inc. $TBBK. $TBBK holds $2B in multifamily bridge loans ("REBLs") and claims the book holds "no substantial risk of losses." We think otherwise. Our full report is now available on our website, culperresearch.com
2) $TBBK has been a sleepy business for a decade plus. But in Q3 2021, $TBBK began originating floating rate REBLs for its own balance sheet. Exposure is now $2.0B, 2.5x $TBBK's equity. Bulls love the decision as $TBBK's multiple has also inflated to 2.5x book value.
3) Despite widely recognized stress in $TBBK's core Class C Sun Belt markets, $TBBK claims "no substantial risk of default and loss." However, using UCCs, liens, deeds, property records, and visits to 21 $TBBK funded properties, we unearthed what we believe are meaningful risks.
1) We are short ACADIA Pharmaceuticals $ACAD. Our full report is now available at culperresearch.com
2) TLDR: Daybue is a total flop. $ACAD misrepresents safety and retention. We think new scripts peaked Aug 2023, revenues will be a fraction of sell-side's $800M+, and knock-on effects are disastrous as $ACAD burns gobs of cash. 3 key insiders have all left in the past 3 months.
3) $ACAD launched Daybue in April 2023 for Rett Syndrome, which has no cure. $ACAD says Daybue side effects are mild, but virtually all see diarrhea, while FAERS data suggests ~1 in 10 are hospitalized. In exchange, just 13% see "much improvement" -- a horrific tradeoff.
1) On Monday, Rumble $RUM announced a "partnership" with Barstool Sports, yet still has not issued a Form 8-K, even now, 4+ business days later. This seems to us like an obvious disclosure issue, especially concerning in light of $RUM's reported ongoing SEC investigation.
2) $RUM's PR appears to claim that a) Barstool will provide content, b) $RUM will give up advertising revenues, and c) Barstool will "get access" to Rumble Cloud (note the passive voice). However, $RUM tellingly omits any financial details - we think they're likely horrendous.
3) Moreover, in a Monday interview with @chrispavlovski, Barstool's Portnoy let it slip that $RUM also paid Barstool both cash and stock ("mostly stock"). This tidbit was conveniently omitted from $RUM's press release, while again Pavlovski declined to provide more information.
1) We are short Jin Medical International Ltd $ZJYL, a China Hustle-style charade. Jin sells wheelchairs and parts in China. In 2022, its revenues fell 8% to just $19M. $ZJYL trades at ~45x revenues. At reasonable "peer" levels of 1-6x sales, $ZJYL shares fall 90% or more.
2) $ZJYL went public in March 2023, underwritten by China-focused chop shop, Prime Number Capital. Prime Number is headquartered in a Long Beach home and has already been sued by investors at least twice for alleged roles in other China frauds. Their track record is horrific.
3) In Sept 2023, $ZJYL faced a NASDAQ delisting notice as it fell under the 300 shareholder threshold required for continued listing. On October 24, $ZJYL CEO Erqi Wang filed a Form 144 to sell 545,893 shares. Then $ZJYL fired its auditor, MarcumAsia, and hired DNTW Toronto.
1) We are short XPEL, Inc. $XPEL. Our full report is now available on our website, culperresearch.com
2) We're short $XPEL for two reasons. First, we believe $XPEL has understated its reliance on Tesla by 5-6x. Second, $XPEL faces an undisclosed, existential threat in its long-time supplier entrotech, which is rendering XPEL useless by going direct to OEMs with paint giant PPG.
3) $XPEL claims TSLA PPFs are just 5% of YTD revenues, but our conversations with literally hundreds of PPF installers suggests otherwise... The 143 installers we surveyed across 26 states told us that Teslas are over 30% of their PPF business, on average.
1) GigaCloud’s $GCT response to our report totally misses the mark.
2) $GCT first claims that its warehouses and trucks are operated not by its own employees, but third parties. This is a lame deflection from our on-ground observations: whether the trucks are owned by GigaCloud or by third parties is not our primary concern: our concern is that we saw so few trucks and such little warehouse activity in the first place. As our initial report stated: “GigaCloud might claim that it outsources its last-mile deliveries using third-party companies as well. However, in this case, we still would have expected to see hundreds of delivery trucks coming and going from the Company’s facilities.” The sparse and haphazard activity we saw at GCT’s warehouses simply fails to square with its claims of a best-in-class e-commerce logistics operation.
3) $GCT then provides a lame appeal to authority by claiming that it has been audited by “KPMG”, but this is again misleading: the Company audited by not by KPMG proper, but by China-based KPMG Huazhen LLP. This is despite the preponderance of the Company’s business based in the U.S. This is also the very same KPMG Huazhen that was charged by the SEC in 2012 for refusing to produce audit work papers for China-based companies and whose 2022 audit inspection found deficiencies at every single audit reviewed.